Remaining measles challenges in Australia

Medical Journal of Australia

Volumn 187, Issue 3, 2007, Pages 181-184

  Durrheim, David N ^a   Kelly, Heath ^b,c   Ferson, Mark J ^d,e   Featherstone, David ^f  

^a HUNTER NEW ENGLAND POPULATION HEALTH   (Australia)

^b VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d South Eastern Sydney and Illawarra Area Health Service   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE;

ANTIBODY SPECIFICITY; ARTICLE; AUSTRALIA; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL PROTOCOL; CONTACT EXAMINATION; ENDEMIC DISEASE; FEVER; GENERAL PRACTITIONER; GENOTYPE; HOSPITAL LABORATORY; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; INFECTION CONTROL; INFECTION PREVENTION; MEASLES; MEASLES VIRUS; PATIENT CARE; PUBLIC HEALTH SERVICE; RASH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS CULTURE;

EID: 34548185411     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2007.tb01182.x     Document Type: Article

References (25)

1. Tobin S, Kelly H. Measles encephalitis in Victoria: down but not out. Aust N Z J Public Health 1999; 23: 443.
2. Anderson RM, May RM. Infectious diseases of humans, Dynamics and control. Oxford: Oxford University Press, 1992: 70.
3. Gidding HF, Wood J, Maclnlyre CR, et al. Sustained measles elimination in Australia and priorities for long term maintenance. Vaccine 2007, 25: 3574-3580.
4. Strebel F, Cochi S, Grabowsky M, et al. The unfinished measles immunization agenda. J Infect Dis 2003, 187 Suppl 1: S1-S7.
5. Communicable Diseases Report for New South Wales for March and April 2006. N S W Public Health Bull 2006; 17: 88-94.
6. Gidding HF. The impact of Australia's measles control programme over the past decade. Epidemiol Infect 2005; 133: 99-105.
7. Wood DL, Brunell PA. Measles control in the United States: problems of the past and challenges for the future. Clin Microbiol Rev 1995; 8: 260-267.
8. Kremer A Schneider F, Muller CR Waning antibodies in measles and rubella vaccines - a longitudinal study. Vaccine 2006; 24: 2594-2601.
9. Riddell MA, Lynch F, Jin L, Chiloo D. Measles case imported from Europe to Victoria, Australia, March 2006. Euro Surveill 2006; 11: E060518.2
10. Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis 2004; 189 Suppl 1: S4-S16.
11. Lambert SB, Kelly HA, Andrews RM, et al, Enhanced measles surveillance during an interepidemic period in Victoria. Med J Aust 2000; 172: 114-118.
12. Weber DJ, Cohen MIS, Fine J-D. The acutely ill patient with fever and rash. In: Mandell GIL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett's principles and practice of infectious disease. 5th ed. Philadelphia: Churchill Livingstone, 2000: 633-650.
13. Scott LA, Stone MS. Viral exanthems. Dermatol Online J 2003, 9: 4.
14. Ferson MJ, Young LC, Robertson PW, Whybin LR. Difficulties in the clinical diagnosis of measles: proposal for modified clinical case definition. Med J Aust 1995; 163: 364-366.
15. Wang YJ, Andrews RM, Lambert SB. Measles surveillance in Victoria, Australia. Bull World Health Organ 2006; 84: 105-111.
16. Dayan GH, Ortega-Sanchez IR, LeBaron CW, Quinlisk MP; Iowa Measles Response Team. The cost of containing one case of measles: the economic impact on the public health infrastructure - Iowa, 2004. Pediatrics 2005: 116: e1-e4.
17. Monitoring the interruption of indigenous measles transmission, Cape Town meeting, 14 October 2003. Wkly Epidemiol Rec 2004; 79: 70-72.
18. Kelly H, Leyclon J. Outbreaks caused by parvovirus B19. Euro Surveill 2005; 10: E1-E2.
19. Dietz V, Rota J, Izurieta H, et al. The laboratory confirmation of suspected measles cases in settings of low measles transmission: conclusions from the experience in the Americas. Bull World Health Organ 2004, 82: 852-857.
20. Jenkin GA, Chibo D, Kelly H, et al. What is the cause of rash in a child following measles-mumps-rubella vaccination? Med J Aust 1999; 171: 194-197.
21. Riddell M, Chibo D, Kelly HA, et al. Investigation of optimal specimen type and sampling time for the detection of measles virus RNA during a measles epidemic. J Clin Microbiol 2001; 39: 375-376.
22. Featherstone D, Brown D, Sanders R. Development of the Global Measles Laboratory Network. J Infect Dis 2003; 187 Suppl 1: S264-S269.
23. National Health and Medical Research Council. The Australian immunisation handbook. 8th ed. Canberra: Australian Government Department of Health and Ageing, 2003: 155. http://www9.health.gov.au/ immhandbook/ (accessed Jun 2007).
24. Ferson MJ, Young LC, Robertson PW, Whybin LR. Difficulties in clinical diagnosis of measles: proposal for modified clinical case definition. Med J Aust 1995; 163: 364-366.
25. National Health and Medical Research Council. Staying healthy in child care. Preventing infectious diseases in child care. 4th ed. Canberra: NHMRC, 2005: 8. http://www.nhmrc.gov.au/publications/synopses/_files/ ch43.pdf (accessed Jun 2007).